274 related articles for article (PubMed ID: 14619957)
21. Malonyl CoA, long chain fatty acyl CoA and insulin resistance in skeletal muscle.
Ruderman NB; Dean D
J Basic Clin Physiol Pharmacol; 1998; 9(2-4):295-308. PubMed ID: 10212840
[TBL] [Abstract][Full Text] [Related]
22. Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle.
Vavvas D; Apazidis A; Saha AK; Gamble J; Patel A; Kemp BE; Witters LA; Ruderman NB
J Biol Chem; 1997 May; 272(20):13255-61. PubMed ID: 9148944
[TBL] [Abstract][Full Text] [Related]
23. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
[TBL] [Abstract][Full Text] [Related]
24. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
Kudo N; Barr AJ; Barr RL; Desai S; Lopaschuk GD
J Biol Chem; 1995 Jul; 270(29):17513-20. PubMed ID: 7615556
[TBL] [Abstract][Full Text] [Related]
25. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
26. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
27. Carnitine palmitoyltransferase I (CPT I) activity and its regulation by malonyl-CoA are modulated by age and cold exposure in skeletal muscle mitochondria from newborn pigs.
Schmidt I; Herpin P
J Nutr; 1998 May; 128(5):886-93. PubMed ID: 9566999
[TBL] [Abstract][Full Text] [Related]
28. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo.
Saha AK; Avilucea PR; Ye JM; Assifi MM; Kraegen EW; Ruderman NB
Biochem Biophys Res Commun; 2004 Feb; 314(2):580-5. PubMed ID: 14733947
[TBL] [Abstract][Full Text] [Related]
29. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
30. MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR: LA-cp rats.
Atkinson LL; Kelly SE; Russell JC; Bar-Tana J; Lopaschuk GD
Diabetes; 2002 May; 51(5):1548-55. PubMed ID: 11978655
[TBL] [Abstract][Full Text] [Related]
31. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation.
Chen ZP; McConell GK; Michell BJ; Snow RJ; Canny BJ; Kemp BE
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1202-6. PubMed ID: 11052978
[TBL] [Abstract][Full Text] [Related]
32. Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth.
Germani D; Puglianiello A; Cianfarani S
Cardiovasc Diabetol; 2008 May; 7():14. PubMed ID: 18485240
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power.
King KL; Okere IC; Sharma N; Dyck JR; Reszko AE; McElfresh TA; Kerner J; Chandler MP; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2005 Sep; 289(3):H1033-7. PubMed ID: 15821035
[TBL] [Abstract][Full Text] [Related]
34. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
Hopkins TA; Dyck JR; Lopaschuk GD
Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
[TBL] [Abstract][Full Text] [Related]
35. Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo.
Saha AK; Laybutt DR; Dean D; Vavvas D; Sebokova E; Ellis B; Klimes I; Kraegen EW; Shafrir E; Ruderman NB
Am J Physiol; 1999 Jun; 276(6):E1030-7. PubMed ID: 10362615
[TBL] [Abstract][Full Text] [Related]
36. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle.
Saha AK; Vavvas D; Kurowski TG; Apazidis A; Witters LA; Shafrir E; Ruderman NB
Am J Physiol; 1997 Apr; 272(4 Pt 1):E641-8. PubMed ID: 9142886
[TBL] [Abstract][Full Text] [Related]
37. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
Alam N; Saggerson ED
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
[TBL] [Abstract][Full Text] [Related]
38. Acute regulation of fatty acid oxidation and amp-activated protein kinase in human umbilical vein endothelial cells.
Dagher Z; Ruderman N; Tornheim K; Ido Y
Circ Res; 2001 Jun; 88(12):1276-82. PubMed ID: 11420304
[TBL] [Abstract][Full Text] [Related]
39. Liver AMP-activated protein kinase and acetyl-CoA carboxylase during and after exercise.
Carlson CL; Winder WW
J Appl Physiol (1985); 1999 Feb; 86(2):669-74. PubMed ID: 9931206
[TBL] [Abstract][Full Text] [Related]
40. AMPK as a metabolic switch in rat muscle, liver and adipose tissue after exercise.
Ruderman NB; Park H; Kaushik VK; Dean D; Constant S; Prentki M; Saha AK
Acta Physiol Scand; 2003 Aug; 178(4):435-42. PubMed ID: 12864749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
